title: Overexpression of Gs alpha protein in the hearts of transgenic mice.
abstract: Alterations in beta-adrenergic receptor-Gs-adenylyl cyclase coupling underlie the reduced catecholamine responsiveness that is a hallmark of human and animal models of heart failure. To study the effect of altered expression of Gs alpha, we overexpressed the short isoform of Gs alpha in the hearts of transgenic mice, using a rat alpha-myosin heavy chain promoter. Gs alpha mRNA levels were increased selectively in the hearts of transgenic mice, with a level 38 times the control. Despite this marked increase in mRNA, Western blotting identified only a 2.8-fold increase in the content of the Gs alpha short isoform, whereas Gs activity was increased by 88%. The discrepancy between Gs alpha mRNA and Gs alpha protein levels suggests that the membrane content of Gs alpha is posttranscriptionally regulated. The steady-state adenylyl cyclase catalytic activity was not altered under either basal or stimulated conditions (GTP + isoproterenol, GTP gamma S, NaF, or forskolin). However, progress curve studies did show a significant decrease in the lag period necessary for GppNHp to stimulate adenylyl cyclase activity. Furthermore, the relative number of beta-adrenergic receptors binding agonist with high affinity was significantly increased. Our data demonstrate that a relatively small increase in the amount of the coupling protein Gs alpha can modify the rate of catalyst activation and the formation of agonist high affinity receptors.
authors.affiliation: Department of Pharmacology, College of Physicians and Surgeons of Columbia University, New York 10032, USA.
authors.forename: C
authors.initials: C
authors.lastname: Gaudin
authors.forename: Y
authors.initials: Y
authors.lastname: Ishikawa
authors.forename: D C
authors.initials: DC
authors.lastname: Wight
authors.forename: V
authors.initials: V
authors.lastname: Mahdavi
authors.forename: B
authors.initials: B
authors.lastname: Nadal-Ginard
authors.forename: T E
authors.initials: TE
authors.lastname: Wagner
authors.forename: D E
authors.initials: DE
authors.lastname: Vatner
authors.forename: C J
authors.initials: CJ
authors.lastname: Homcy
mesh_terms: D000262:Adenylyl Cyclases / Q000378:metabolism*; D000318:Adrenergic beta-Agonists / Q000378:metabolism; D000818:Animals; D004789:Enzyme Activation / Q000187:drug effects; D019204:GTP-Binding Proteins / Q000096:biosynthesis* / Q000235:genetics*; D006165:Guanylyl Imidodiphosphate / Q000494:pharmacology; D006333:Heart Failure / Q000209:etiology; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism*; D011401:Promoter Regions, Genetic / Q000235:genetics; D011943:Receptors, Adrenergic, beta / Q000378:metabolism; D011994:Recombinant Proteins / Q000096:biosynthesis; D012508:Sarcolemma / Q000201:enzymology / Q000378:metabolism*
chemical_list: D000318:Adrenergic beta-Agonists; D011943:Receptors, Adrenergic, beta; D011994:Recombinant Proteins; D006165:Guanylyl Imidodiphosphate; D019204:GTP-Binding Proteins; D000262:Adenylyl Cyclases